BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12467540)

  • 1. [Impact of invasive pneumococcal infection in children].
    Sáez-Llorens X
    An Esp Pediatr; 2002 Nov; 57(5):391-3. PubMed ID: 12467540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001].
    Iglesias Sánchez L; Pérez-Yarza EG; García-Arenzana JM; Valiente Méndez A; Pérez-Trallero E
    An Esp Pediatr; 2002 Nov; 57(5):401-7. PubMed ID: 12467542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
    Calbo E; Díaz A; Cañadell E; Fábrega J; Uriz S; Xercavins M; Morera MA; Cuchi E; Rodríguez-Carballeira M; Garau J;
    Clin Microbiol Infect; 2006 Sep; 12(9):867-72. PubMed ID: 16882291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of pneumococcal bloodstream infections.
    Rodríguez-Créixems M; Bertó J; Muñoz P; Alonso R; Alcalá L; Bouza E
    Pediatr Infect Dis J; 2003 Jul; 22(7):661-3. PubMed ID: 12886897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain).
    Navas E; Salleras L; Gisbert R; Domínguez A; Timoner E; Ibáñez D; Prat A
    Vaccine; 2005 Mar; 23(17-18):2342-8. PubMed ID: 15755625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
    Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
    Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
    Abzug MJ; Pelton SI
    J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal infection in first nations children in northern Alberta.
    Vaudry W; Talling D
    Can Commun Dis Rep; 2002 Oct; 28(20):165-72. PubMed ID: 12402519
    [No Abstract]   [Full Text] [Related]  

  • 16. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
    Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
    [No Abstract]   [Full Text] [Related]  

  • 17. Universal pneumococcal vaccination for India.
    Mathew JL
    Indian Pediatr; 2008 Feb; 45(2):160-1. PubMed ID: 18310801
    [No Abstract]   [Full Text] [Related]  

  • 18. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
    Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
    Bjornson G; Scheifele DW; Bettinger J; Patrick DM; Gustafson L; Daly P; Tyrrell GJ
    Pediatr Infect Dis J; 2007 Jun; 26(6):540-2. PubMed ID: 17529875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Considerations on pediatric pneumococcal infection in Navarra].
    Bernaola E; Herranz M; Clerigué N; Torroba L; Gil F; Gil-Setas A
    Rev Esp Quimioter; 2007 Mar; 20(1):143-9. PubMed ID: 17530048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.